Insecticides (India) Limited (IIL), one of India’s leading fully integrated crop protection and nutrition company, has announced its unaudited financial results for the quarter and six months ended September 30, 2026. The company reported an 8% net revenue growth in Q2 FY27, standing at Rs 686 cr compared to Rs 638 cr in Q2 FY26. Despite weather-related disruptions, IIL maintained margin stability through premiumisation and effective cost optimization.

Strategic Priorities and Innovations

IIL remains focused on executing its strategic priorities amid otherwise muted demand conditions. The company has invested in manufacturing capabilities, particularly at Sotanala and Dahej, to expand capacity and enhance backward integration. Additionally, IIL launched two new products, Granuvia and Spinoace, through international collaborations.

Farmer Engagement and Expansion

The company conducted over 18,000 farmer meetings, 9,000 field days, and demonstrations, and connected with 10 lakh farmers through direct field activities during H1 FY27. The IIL Crop Solutions (ICS) program is being expanded to 16 states across four key crops, demonstrating tangible improvements in farm economics.

Commenting on the results, Mr. Rajesh Kumar Aggarwal, MD of IIL, said: ‘While the first half witnessed weather-related disruptions across key agricultural regions, we remained focused on strengthening the building blocks of our long-term growth strategy. Our continued emphasis on premiumisation and operating efficiencies has supported constituency in margins. Looking ahead, we remain focus on internal priorities, profitable growth, and improvement in cash flow generation.’

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Insecticides (India) Limited

Insecticides (India) Limited belongs to the Basic Materials › Agricultural Inputs sector. Here’s a quick read on where the business and the stock stand today.

Insecticides falls 11.2% over three months and has not found a floor yet. The PEG of 0.45 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Thin margins at 6.1% leave limited room for error — any demand softness or cost spike hits the bottom line hard. The stock sits at 24% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 5.9% and profits at 30.2% CAGR, with D/E of 0.00. Meanwhile, the stock dips 11.2% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Insecticides (India) Limited.

Berger Paints (I) Limited showcased robust financial performance for Q2 & H1 FY27, with standalone revenue growth of 11.9% and consolidated revenue up 13.2%. PBDIT (consolidated) grew by 5.2%, driven by strong performances from subsidiaries.

Decorative Business

The Decorative Business witnessed near double-digit value growth, primarily driven by price increases of ~8%.

Industrial Business

The Industrial Business demonstrated robust volume and value growth across all business lines, although gross margins were lower on a YoY basis due to double-digit RM inflation, liquidation of high-cost inventory, and delayed price increases in the Industrial segment.

Financial Highlights

The company continues to remain cash-positive on a consolidated basis. PBDIT margin compression was relatively contained, with additional investment of ~₹22 crore in the Rang Bana Rahe campaign impacting quarterly margins. Excluding this, PBDIT growth would have been ~3%.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Berger Paints (I) Limited

Berger Paints (I) Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Berger moves sideways over three months, with neither buyers nor sellers taking control. The PEG stands at 4.78 — severely stretched. Any earnings miss could trigger a sharp de-rating. Thin margins at 9.9% leave limited room for error — any demand softness or cost spike hits the bottom line hard. The stock gains 5.8% in the last month, recovering from the three-month slide. However, it is too early to call this a confirmed reversal. Revenue grows at 4.2% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Berger Paints (I) Limited.

Gujarat Alkalies and Chemicals Limited (GUJALKALI) has reported its highest-ever quarterly and half yearly revenue in FY 2026-27. The board approved the unaudited financial results for the 2nd quarter ended on 30th September 2026, showing significant growth. Smt. Avantika Singh, IAS, Managing Director, highlighted the company’s growth momentum and the highest-ever quarterly and half yearly sales revenue in the last two decades.

Quarterly Performance

For the 2nd quarter, sales revenue increased by Rs.271.60 crores (26%) to Rs.1,334.79 crores compared to Rs.1,063.19 crores in the corresponding quarter of the previous year. EBITDA surged by Rs.88.67 crores (67%) to Rs.221.86 crores, while profit before tax jumped by Rs.88.62 crores (657%) to Rs.102.10 crores.

Half Yearly Growth

For the first half of the year, sales revenue rose by Rs.422.99 crores (20%) to Rs.2559.63 crores compared to Rs.2,136.64 crores in the corresponding period of the previous year. EBITDA increased by Rs.192.91 crores (75%) to Rs.451.19 crores, and profit before tax climbed by Rs.189.11 crores (821%) to Rs.212.14 crores.

Renewable Energy Focus

The company has significantly increased its renewable energy share, aligning with India’s net-zero carbon commitments. The share of renewable energy rose to 55% in the second quarter and 57% in the first half, up from 38% in the corresponding periods of the previous year. This strategic focus on renewable energy has also contributed to reducing energy costs.

GUJALKALI continues to implement strategic growth projects, including the Phosphoric Acid Plant-II and investments in renewable energy, which are expected to enhance operating efficiency and reduce costs. These initiatives align with the Vision 2047 document, supporting the national vision of Viksit Bharat @2047.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Gujarat Alkalies and Chemicals Limited

Gujarat Alkalies and Chemicals Limited belongs to the Basic Materials › Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Gujarat moves sideways over three months, with neither buyers nor sellers taking control. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. Revenue contracts at -1.2% CAGR. That signals structural headwinds, not a short-term blip. The stock holds at 43% of its 52-week range with RSI at 35. In other words, neither side has a clear edge right now. Revenue grows at -1.2% CAGR and the PEG stands at 99.00. The growth does not match the price the market asks. Furthermore, flat price action adds no technical catalyst. A lower price or faster revenue growth would improve the odds. Check Fundamentals of Gujarat Alkalies and Chemicals Limited.